Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Upstream transcription factor 1 (USF1) is a ubiquitously expressed transcription factor belonging to the basic helix-loop-helix leucine zipper (bHLH-LZ) family. USF1 recognizes E-box motifs in gene promoters and regulates transcription bidirectionally, being able to activate or repress target genes. Its DNA binding is modulated by post-translational modifications, notably phosphorylation by MAPK and PKC pathways. USF1 orchestrates numerous biological processes including immune response, inflammation, cell cycle control, DNA damage response, and lipid metabolism. It plays key roles in cancer development, cardiovascular disease, viral infection responses, and pigmentation. USF1’s transcriptional targets include both protein-coding and non-coding RNAs, and it exerts its function through both direct promoter binding and indirect modulation of chromatin biology. Loss or dysregulation of USF1 activity has been implicated in tumorigenesis and metabolic syndromes.
Not applicable—USF1 is not targeted by approved drugs. Its regulatory activity may be indirectly modulated by signaling cascades (e.g., phosphorylation via ERK1/2 or PKC impacts its DNA binding and activity).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream transcription factor 1 (USF1).